alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1
       EXHIBIT 10(l) TO ANNUAL REPORT ON FORM 10-K FOR SYMIX SYSTEMS, INC.


                              SUMMARY OF BONUS PLAN

         The executive officers named in the Symix Systems, Inc. ("Symix" or the
"Company") Annual Report on Form 10-K for its fiscal year ended June 30, 2000
and other management employees of Symix ("Participants") participate in
compensation plans based upon the performance of Symix. Annual target bonuses
are established by the Symix Compensation Committee for executive officers and
by executive officers for all other Participants. Total targeted compensation is
determined based on average compensation (base compensation plus bonus) levels
for the industry. Under the Company's fiscal year 2000 plan (the "Plan"), a
Participant can earn a bonus based upon the performance of Symix as reflected by
Symix's earnings per share and revenue achievements in relation to its targeted
performance. Bonuses for revenue achievement are paid quarterly based upon
year-to-date performance. Quarterly eligible components are pro-rated against
targeted annual objectives. Bonuses are based on formulas which provide larger
bonuses for higher earnings per share and/or revenue achievement. The annual
earnings per share must be at least ninety percent (90%) of target before any
bonuses are earned. Variable components of the compensation plan are
self-correcting to reflect over or under achievement on a quarterly basis. A
maximum of 200% of the targeted bonus based on earnings per share and revenue
objectives is payable under the compensation plans in the event actual
performance of the Company exceeds 150% of targeted performance. In addition,
individual bonus plans may contain other variable components related to
management objectives, operating margins, and market or geographic revenue
targets. The Company's Chief Executive Officer is not a participant in the Plan
and his compensation is covered by his Employment Agreement with the Company.
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

January 24, 2008 Clifford W. Taylor, Chief Justice

134936 Michael F. Cavanagh
Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan DENISE MOYER, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman,
Justices

v SC: 134936 COA: 276154 Macomb CC: 05-001443-NI NANCY SIELOFF and KENNETH SIELOFF, Defendants-Appellants.

________________ _______________ __________/

On order of the Court, the applicati on for leave to appeal the August 14, 2007 order of the Court of Appeals is considered and, pursuant to MCR 7.302(G)(1), in lieu of granting leave to appeal, we REVERSE the decision of the Macomb Circuit Court denying summary disposition to the defendan ts on the ground th at the defendants’ knowledge of an ice hazard rendered the open and obvious doctrine inapplicable. Because the plaintiff was a licensee, the defe ndants only had a duty to warn the plaintiff of hidden dangers known to the defendants. Stitt v Holland Abundant Life , 452 Mich 591, 596 (2000). The fact that the danger was known to the defendants does not mean that the danger was hidden to the plaintiff. We REMAND this case to the Macomb
Circuit Court for further cons ideration of the defendants’ motion for summary disposition to determine whether the icy condition that allegedly caused the plaintiff’s injury was open and obvious. Lugo v Ameritech , 464 Mich 512 (2001).

We do not retain jurisdiction.

t0117 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

January 24, 2008

Clerk
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
UNAUDITED   CONDENSED   CONSOLIDATED   FINANCIAL   STATEMENTS  INCLUDED  IN  THE
REGISTRANT'S  FORM 10-Q FOR THE PERIOD  ENDED JUNE 30, 1999 AND IS  QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FORM 10-Q.
</LEGEND>
<CIK>                         0001012270
<NAME>                        CollaGenex Pharmaceuticals, Inc.
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U. S. Dollars

<S>                                            <C>
<PERIOD-TYPE>                                  6-mos
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 JAN-01-1999
<PERIOD-END>                                   JUN-30-1999
<EXCHANGE-RATE>                                1
<CASH>                                         21,640
<SECURITIES>                                   0
<RECEIVABLES>                                  1,373
<ALLOWANCES>                                   337
<INVENTORY>                                    634
<CURRENT-ASSETS>                               24,046
<PP&E>                                         796
<DEPRECIATION>                                 183
<TOTAL-ASSETS>                                 24,698
<CURRENT-LIABILITIES>                          5,943
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    2
<COMMON>                                       86
<OTHER-SE>                                     18,524
<TOTAL-LIABILITY-AND-EQUITY>                   24,698
<SALES>                                        5,620
<TOTAL-REVENUES>                               5,856
<CGS>                                          1,253
<TOTAL-COSTS>                                  15,254
<OTHER-EXPENSES>                               2
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             189
<INCOME-PRETAX>                                (9,230)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (9,230)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (9,230)
<EPS-BASIC>                                  (1.10)
<EPS-DILUTED>                                  (1.10)


</TABLE>
### TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED JANUARY 1 4 , 2021

NO. 03

- 19

- 00478

- CR

Sisto Quiroz, III, Appellant

v.

The State of Texas, Appellee

APPEAL FROM THE 277TH DISTRICT COURT OF WILLIAMSON COUNTY

BEFORE JUSTICES BAKER , TR IANA, AND KELLY

AFFIRMED

-- OPINION BY JUSTICE BAKER

This is an appeal from the judgments of conviction entered by the trial court. Having reviewed

the record an d th e parties’ arguments, the Court holds that there was no reversible error in

the judgments

. Therefore, the Court affirms the trial court’s judgments of conviction

. Becau se

appellant is indigen t and u nable to pay costs, no adjudica t i on of costs is made.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                                        <C>
<PERIOD-TYPE>                              6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                      12,954,000
<SECURITIES>                                         0
<RECEIVABLES>                               17,521,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            33,370,000
<PP&E>                                       3,853,000
<DEPRECIATION>                                 751,000
<TOTAL-ASSETS>                              57,660,000
<CURRENT-LIABILITIES>                       12,255,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        10,000
<OTHER-SE>                                  36,507,000
<TOTAL-LIABILITY-AND-EQUITY>                57,660,000
<SALES>                                     73,962,000
<TOTAL-REVENUES>                            73,962,000
<CGS>                                       40,877,000
<TOTAL-COSTS>                               73,047,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (406,000)
<INCOME-PRETAX>                              1,321,000
<INCOME-TAX>                                   515,000
<INCOME-CONTINUING>                            806,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   806,000
<EPS-PRIMARY>                                      .09
<EPS-DILUTED>                                      .09
        

</TABLE>
### Schaeffer, John From: Sent: To: 

### Cc: Subject: Lin , Chuantung Thursday , Apri l 24 ! 2014 2:46 PM Schaeffer , John Williamson , Tracy ; L

Christian , Myrta RE : HPV 3 Test R le Data Submission 5026-74-4 

### HiJohn, 

# I I Sorry to miss that. Yes

. After look at the HPLC measured data, it is OK to accept this measured Log Kow data fro m the surogate for the HPV 3 test chemical. Daniel From : Schaeffer, John Sent: Thursday, Apr i l 

### 24 , 2014 2:34 PM To: Lin, Chuantung 

### Cc: Williamson, Tracy; Christian, Myrta Subject: RE: HPV 

### 3 Test Ru le Data Submission 

### 5 026-74

-4 Daniel, It looks like they did it both ways- take a loo kJ at the pdf attachment again · - it looks like they used the HPLC method for the surrogate chemica l Thanks, John John Schaeffer Senior B iologist USEPA/OPPT/CCO/CITB 1201 Constitution Ave , NW Washington, DC 20460 Mail Code: 7405M Phone:202-564-8173
Exhibit 99.2



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the quarterly report on Form 10-Q of Boston Communications Group, Inc. (the Company) for the period ended March 31, 2003 as filed with the Securities and Exchange Commission on the date hereof
(the Report), the undersigned, Karen A. Walker, Vice President, Finance and Administration and Chief Financial Officer, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:



| | (1) |  | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- |  | ---------------------------------------------------------------------------------------------------------------------



| | (2) |  | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------



A signed original of this written
statement required by Section 906 has been provided to Boston Communications Group, Inc., and will be retained by Boston Communications Group, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.



|                  
|------------------
|Date: May 15, 2003
|
##### 



Exhibit 32 Certification Required by 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002) I, Roy T. Rimmer, Jr. as Principal Executive and Financial Officer of TIMCO
Aviation Services, Inc. (the Company), certify, pursuant to 18 U.S.C. Section
1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002),
that to my knowledge:  1.
    
    the accompanying Quarterly Report on Form 10-Q of the Company for the
quarterly period ended September 30, 2004 (the Report), filed with the
U.S. Securities and Exchange Commission, fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended; and2.
    
    the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of
the Company. Date: November 15, 2004
    /s/ Roy T. Rimmer,
Jr.Roy T. Rimmer, Jr.Chief Executive Officer
(Principal Executive and Financial Officer) 32
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                          35,794
<SECURITIES>                                         0
<RECEIVABLES>                                  577,217
<ALLOWANCES>                                         0
<INVENTORY>                                  2,929,980
<CURRENT-ASSETS>                             3,651,594
<PP&E>                                         405,156
<DEPRECIATION>                                 133,563
<TOTAL-ASSETS>                               4,043,719
<CURRENT-LIABILITIES>                        1,802,311
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         3,150
<OTHER-SE>                                   2,238,258
<TOTAL-LIABILITY-AND-EQUITY>                 4,043,719
<SALES>                                      1,343,456
<TOTAL-REVENUES>                             1,343,456
<CGS>                                          641,123
<TOTAL-COSTS>                                1,137,155
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              14,895
<INCOME-PRETAX>                                449,717
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            449,717
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   449,717
<EPS-PRIMARY>                                      .14
<EPS-DILUTED>                                      .14
        

</TABLE>
<page>			            EXHIBIT 32.01



CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of Morgan Stanley Spectrum
Select L.P. (the "Partnership") on Form 10-K for the period ended
December 31, 2003 as filed with the Securities and Exchange
Commission on the date hereof (the "Report"), I, Jeffrey A.
Rothman, President, Demeter Management Corporation, the general
partner of the Partnership, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that, to the best of my knowledge:
(1)	The Report fully complies with the requirements of Section
13 or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents,
in all material respects, the financial condition and
results of operations of the Partnership.





By:	  /s/	Jeffrey A. Rothman

Name:		Jeffrey A. Rothman
Title:	President

Date:		March 15, 2004
Exhibit 32.2

                 Written Statement of Chief Financial Officer
          Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

In connection with the Annual Report of Jeffersonville Bancorp (the
"Company") on Form 10-K for the period ending December 31, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned hereby certifies to his knowledge on the date hereof, that:

     1.   The Report fully complies with the requirements of section 13(a) of
          the Securities Exchange Act of 1934; and

     2.   The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations
          of the Company.

    A signed original of this written statement required by Section 906, or
other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to
Jeffersonville Bancorp and will be retained by Jeffersonville Bancorp and
furnished to the Securities and Exchange commission or its staff upon
request.

                                       /s/ Charles E. Burnett
                                       Charles E. Burnett
March 29, 2005                         Treasurer and Chief Financial Officer
<PAGE>

                                                                    Exhibit 32.1


              CERTIFICATION PURSUANT TO SECTION 1350 OF CHAPTER 63
                         OF TITLE 18 UNITED STATES CODE



         Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections
(a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the
undersigned officer of CITGO Petroleum Corporation (the "Registrant"), does
hereby certify, to his knowledge, that:


         The Quarterly Report on Form 10-Q for the quarter ended March 31, 2003
of the Registrant fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934 and information contained in the Form
10-Q fairly presents, in all material respects, the financial condition and
results of operations of the Registrant.


Dated: September 8, 2003                             /s/ Luis E. Marin
                                                  ------------------------------
                                                  Name:  Luis E. Marin
                                                  Title: Chief Executive Officer
[Federal Register Volume 89, Number 176 (Wednesday, September 11, 2024)]
[Notices]
[Page 73654]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20607]


=======================================================================
-----------------------------------------------------------------------

FEDERAL FINANCIAL INSTITUTIONS EXAMINATION COUNCIL

[Docket No. AS24-17]


Appraisal Subcommittee Notice of Meeting

AGENCY: Appraisal Subcommittee of the Federal Financial Institutions 
Examination Council

ACTION: Notice of special closed meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 1104(b) of title XI of the 
Financial Institutions Reform, Recovery, and Enforcement Act of 1989, 
as amended (title XI), notice is hereby given that the Appraisal 
Subcommittee (ASC) met for a Special Closed Meeting on these dates.

Location: Virtual meeting via Teams
Date: July 10, 2024
Time: 10:45 a.m. ET
Location: Virtual meeting via Teams
Date: August 14, 2024
Time: 11:00 a.m. ET
Location: Virtual meeting via Teams
Date: September 4, 2024
Time: 11:15 a.m. ET

Action and Discussion Item

Personnel Matter

    The ASC convened a Special Closed Meeting to discuss a personnel 
matter pursuant to section 1104(b) of Title XI (12 U.S.C. 3333(b)). No 
action was taken by the ASC.

Loretta Schuster,
Management & Program Analyst.
[FR Doc. 2024-20607 Filed 9-10-24; 8:45 am]
BILLING CODE 6700-01-P
[Federal Register Volume 89, Number 175 (Tuesday, September 10, 2024)]
[Notices]
[Page 73488]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20317]


-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice:12500]


Certification Pursuant to Section 7041(A)(2) of the Department of 
State, Foreign Operations, and Related Programs Appropriations Act, 
2024

    By virtue of the authority vested in me as Secretary of State 
pursuant to section 7041(a)(2) of the Department of State, Foreign 
Operations, and Related Programs Appropriations Act, 2024 (Div. F, Pub. 
L. 118-47), I hereby certify that the Government of Egypt is sustaining 
the strategic relationship with the United States and meeting its 
obligations under the 1979 Egypt-Israel Peace Treaty.
    This certification shall be published in the Federal Register and, 
along with the accompanying Memorandum of Justification, shall be 
reported to Congress.

    Dated: May 31,2024.
Antony J. Blinken,
Secretary of State.
[FR Doc. 2024-20317 Filed 9-9-24; 8:45 am]
BILLING CODE 4710-315-P
Exhibit 11.1
                      EP MEDSYSTEMS, INC.
        STATEMENT OF COMPUTATION OF EARNINGS PER SHARE
                  Three Months Ended    Nine Months Ended
                    September 30,         September 30,
                    1995         1996         1995         1996
Net loss        $ (256,327)  $ (333,341)  $ (550,429)  $ (595,021)
                                                                  
Weighted average shares
outstanding:
Common stock      4,518,667    7,581,167    4,518,667    5,648,566
(1)
Stock options       909,055            0      909,055      602,707
(2) (3)
Warrants (2) (3)    361,932            0      361,932      239,962

                  5,789,654    7,581,167    5,789,654    6,491,235
Historical net                                                    
loss            $     (.04)  $     (.04)  $     (.10)  $     (.09)
per share
                                                                  

(1)  93,500 and 166,667 shares of stock were issued in 1995 and
1996,  respectively.  These shares were issued within 12 months
preceding  the filing of the registration statement  at  prices
lower  than  the  initial public offering price.   Pursuant  to
Staff Accounting Bulletin No. 83 such shares have been included
in  the  weighted average number of shares outstanding for  the
three  and nine month periods ended September 30, 1995 and  the
nine months ended September 30, 1996.

(2)  Options and warrants at 909,055 and 361,932, respectively,
were granted at prices below the initial public offering price.
The  dilutive effect of these options have been included in the
earnings per share calculation using the treasury stock  method
in  accordance  with SAB No. 83 for the three  and  nine  month
periods  ended September 30, 1995.  For the nine  months  ended
September  30,  1996,  these options  and  warrants  have  been
included  in  the Company's loss per share computation  through
June  30,  1996,  the  period during which the  initial  public
offering  became  effective, using the treasury  stock  method,
even though they were anti-dilutive.

                              Options       Warrants
   Options issued within      1,324,000        568,750
   one year
   Proceeds from          $   2,282,200  $   1,137,500
   exercise
   Public offering price        / $5.50        / $5.50
   Treasury stock               414,945        206,818
   Incremental shares           909,055        361,932

(3)    Options  and  warrants  have  been  excluded  from   the
calculation  of earnings per share for the three  months  ended
September 30, 1996 because they are anti-dilutive.